Victoza (liraglutide) is a once-daily injection to treat type 2 diabetes in adults. Victoza is intended to help lower blood sugar levels along with diet, exercise, and selected other diabetes medicines. It is not recommended as initial therapy in patients who have not achieved adequate diabetes control on diet and exercise alone.

Ustekinumab (Stelara) is given by subcutaneous injection and targets the body's immune system by inhibiting the action of IL-12 and IL-23, two proteins that may be involved in plaque psoriasis.

An IV calcium channel blocker to reduce BP from The Medicines Company

Alvesco (ciclesonide) from Sepracor Pharmacologic is an inhaled corticosteroid with indication for maintenance treatment of asthma as prophylactic therapy.

Relistor (methylnaltrexone bromide) from Wyeth, an opioid antagonist with indication for opioid-induced constipation; for subcutaneous (SC) injection.

Evamist (estradiol), from Ther-Rx, a transdermal spray of pharmacologic class estrogen; for moderate-to-severe vasomotor symptoms associated with declining estrogen levels during menopause.

Treximet (sumatriptan [as succinate]) 85 mg, naproxen sodium 500 mg tablets (selective 5-HT1B/1D receptor agonist + NSAID); from GlaxoSmithKline; for acute treatment of migraine.

More help for depression

Targeted rhinitis relief